ZA984638B - Azacyclooctane and heptane derivatives their preparation and use - Google Patents
Azacyclooctane and heptane derivatives their preparation and useInfo
- Publication number
- ZA984638B ZA984638B ZA984638A ZA984638A ZA984638B ZA 984638 B ZA984638 B ZA 984638B ZA 984638 A ZA984638 A ZA 984638A ZA 984638 A ZA984638 A ZA 984638A ZA 984638 B ZA984638 B ZA 984638B
- Authority
- ZA
- South Africa
- Prior art keywords
- monocyclic
- aryl
- heteroaryl group
- alkynyl
- cycloalkyl
- Prior art date
Links
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical class CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 title 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 title 1
- -1 thiocycloalkoxy Chemical group 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000002950 monocyclic group Chemical group 0.000 abstract 5
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000004104 aryloxy group Chemical group 0.000 abstract 3
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000005309 thioalkoxy group Chemical group 0.000 abstract 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 108010009685 Cholinergic Receptors Proteins 0.000 abstract 1
- 102000034337 acetylcholine receptors Human genes 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK62997 | 1997-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA984638B true ZA984638B (en) | 1998-12-11 |
Family
ID=8095755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA984638A ZA984638B (en) | 1997-05-30 | 1998-05-29 | Azacyclooctane and heptane derivatives their preparation and use |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6420395B1 (de) |
| EP (1) | EP0984943B1 (de) |
| JP (1) | JP2002511068A (de) |
| CN (1) | CN1124266C (de) |
| AT (1) | ATE229509T1 (de) |
| AU (1) | AU736547B2 (de) |
| CA (1) | CA2289576A1 (de) |
| DE (1) | DE69810107T2 (de) |
| DK (1) | DK0984943T3 (de) |
| NZ (1) | NZ500644A (de) |
| WO (1) | WO1998054152A1 (de) |
| ZA (1) | ZA984638B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070191815A1 (en) | 2004-09-13 | 2007-08-16 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| ES2521494T3 (es) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos |
| CN102516172B (zh) * | 2011-11-25 | 2013-09-04 | 中国农业大学 | 一种2,3,4,7-四氢-1h-氮杂卓类化合物及其制备方法与应用 |
| US10213438B2 (en) | 2014-11-18 | 2019-02-26 | Mymd Pharmaceuticals, Inc. | Alkaloid compounds for treating depression, substance addictions, and indications associated with chronic inflammation |
| WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| US9637488B2 (en) * | 2015-01-29 | 2017-05-02 | Fuqiang Ruan | Heterocyclic compounds as inhibitors of class I PI3KS |
| WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
| CA3251740A1 (en) * | 2022-05-05 | 2023-11-09 | Philip Morris Products S.A. | NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3133073A (en) | 1959-12-10 | 1964-05-12 | Sterling Drug Inc | 3-aryl-1, 5-iminocycloalkanes and preparation thereof |
| FR1372838A (fr) | 1962-10-13 | 1964-09-18 | Basf Ag | Composés bicycliques et procédé pour leur préparation |
| DE1174793B (de) | 1962-11-13 | 1964-07-30 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von 3ª‡-Phenyl-granatanen und ihren Hydrohalogeniden |
| US3509161A (en) | 1967-07-10 | 1970-04-28 | Boehringer & Soehne Gmbh | 3-phenyl-granatene-(2)-derivatives |
| US3935199A (en) * | 1969-10-01 | 1976-01-27 | Mead Johnson & Company | Iminomethylindolines |
| IL59004A0 (en) | 1978-12-30 | 1980-03-31 | Beecham Group Ltd | Substituted benzamides their preparation and pharmaceutical compositions containing them |
| EP0093488A3 (de) | 1982-03-18 | 1984-05-23 | Beecham Group Plc | Nortropyl-Benzopyrrolinon-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
| US5015741A (en) * | 1989-10-03 | 1991-05-14 | Philip Morris Incorporated | Nicotine analogs |
| JP2657583B2 (ja) | 1991-03-01 | 1997-09-24 | ユニバーシテイ オブ フロリダ リサーチ ファンデーション インコーポレイテッド | 神経系変性疾患の治療に対するニコチン類似体の利用 |
| DK0588917T3 (da) | 1991-05-29 | 2001-02-12 | Abbott Lab | Isoxazol- og isothiazolforbindelser, som forstærker kognitiv funktion |
| AU4704593A (en) | 1992-08-06 | 1994-03-03 | Smithkline Beecham Plc | 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
| WO1995000508A1 (en) * | 1993-06-25 | 1995-01-05 | Smithkline Beecham Plc | Phenyrrole derivatives and their use as dopamine d3 antagonists |
| JPH11512443A (ja) | 1995-09-22 | 1999-10-26 | ノボ ノルディスク アクティーゼルスカブ | 新規な置換アザ環式またはアザ二環式化合物 |
-
1998
- 1998-05-29 CA CA002289576A patent/CA2289576A1/en not_active Abandoned
- 1998-05-29 CN CN98805416A patent/CN1124266C/zh not_active Expired - Fee Related
- 1998-05-29 ZA ZA984638A patent/ZA984638B/xx unknown
- 1998-05-29 AU AU74262/98A patent/AU736547B2/en not_active Ceased
- 1998-05-29 AT AT98921379T patent/ATE229509T1/de not_active IP Right Cessation
- 1998-05-29 DK DK98921379T patent/DK0984943T3/da active
- 1998-05-29 EP EP98921379A patent/EP0984943B1/de not_active Expired - Lifetime
- 1998-05-29 NZ NZ500644A patent/NZ500644A/en unknown
- 1998-05-29 JP JP50013199A patent/JP2002511068A/ja not_active Withdrawn
- 1998-05-29 WO PCT/DK1998/000226 patent/WO1998054152A1/en not_active Ceased
- 1998-05-29 DE DE69810107T patent/DE69810107T2/de not_active Expired - Lifetime
-
1999
- 1999-11-29 US US09/450,636 patent/US6420395B1/en not_active Expired - Fee Related
-
2002
- 2002-04-30 US US10/134,498 patent/US6680314B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE229509T1 (de) | 2002-12-15 |
| EP0984943B1 (de) | 2002-12-11 |
| DE69810107T2 (de) | 2003-08-21 |
| DE69810107D1 (de) | 2003-01-23 |
| US6420395B1 (en) | 2002-07-16 |
| US6680314B2 (en) | 2004-01-20 |
| AU736547B2 (en) | 2001-08-02 |
| JP2002511068A (ja) | 2002-04-09 |
| DK0984943T3 (da) | 2003-03-17 |
| CA2289576A1 (en) | 1998-12-03 |
| US20020169156A1 (en) | 2002-11-14 |
| WO1998054152A1 (en) | 1998-12-03 |
| CN1124266C (zh) | 2003-10-15 |
| EP0984943A1 (de) | 2000-03-15 |
| NZ500644A (en) | 2001-08-31 |
| AU7426298A (en) | 1998-12-30 |
| CN1257485A (zh) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA984640B (en) | 9-Azabicyclo[3.3.1]non-2-ene and nonane derivatives their preparations and use | |
| CA2289574A1 (en) | 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors | |
| ZA984637B (en) | Spiro-quinuclidine derivatives their preparation and use | |
| MY114679A (en) | Aroyl-piperidine derivatives | |
| MY104179A (en) | Antidepressant n-substituted nicotinamide compounds. | |
| NZ220106A (en) | Antidepressant heterocyclic compounds and pharmaceutical compositions | |
| AU8149894A (en) | Substituted phenyl compounds | |
| AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
| ES467565A1 (es) | Procedimiento para la preparacion de nuevas 4-acilamino-fe- nil-etanol-aminas. | |
| ES468173A1 (es) | Un procedimiento para la preparacion de derivados de morfina | |
| ATE229509T1 (de) | Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung | |
| ATE247104T1 (de) | Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren | |
| ES475173A1 (es) | Procedimiento para la fabricacion de quinazolinas. | |
| MY131762A (en) | Pharmaceutical compounds | |
| ES8400440A1 (es) | "procedimiento para preparar nuevas triazoloquinazolonas". | |
| IE56000B1 (en) | 1-arylcyclobutylalkylamine compounds | |
| GB9904275D0 (en) | Anti-cancer compounds | |
| ATE43588T1 (de) | Benzofuranderivate, verfahren zu ihrer herstellung und sie enthaltende antihypertensive mittel. | |
| ES468170A1 (es) | Un procedimiento para la preparacion de un nuevo derivado demorfina | |
| ES2104688T3 (es) | Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido. | |
| IE893211L (en) | Benzoxazepinone Process | |
| GB8728949D0 (en) | Heterocyclic amino compounds | |
| DE3264708D1 (en) | 4-aryloxy-1,2,3,4-tetrahydroisoquinolines, and intermediates, a process for preparing the same, a pharmaceutical composition containing the same and their use as medicaments | |
| KR890002168A (ko) | 디하이드로-1,4-옥사지노[2,3-c]퀴놀린, 그의 제조방법 및 중간생성물 및 약제로서의 용도 | |
| ES8301480A1 (es) | Un procedimiento para la produccion de derivados de 11-piperazinil-5h--pirrolo 1,2-b, 1,2,5 benzotriazepina. |